ecancermedicalscience

Review

Denis Burkitt and the African lymphoma

30 Sep 2009
I Magrath

Burkitt lymphoma has provided a model for the understanding of the epidemiology, the molecular abnormalities that induce tumours, and the treatment of other lymphomas. It is important to remember that the early phases of this work were conducted in Africa where today, unfortunately, the disease usually results in death because of limited resources, even though most children in more developed countries are cured. This must be changed. In addition, it is time to re-explore, with modern techniques, some of the questions that were raised some 50 years ago shortly after Burkitt’s first description, as well as new questions that can be asked only in the light of modern understanding of the immune system and the molecular basis of tumor development. The African lymphoma has taught us much, but there is a great deal still to be learned.

Related Articles

Soumitra Shankar Datta, Soumita Ghose, Manisha Ghosh, Amruta Jain, Sumedha Mandal, Sayan Chakraborty, Carlo Caduff
Foziya Mohammed Hussien, Anissa Mohammed Hassen, Zinet Abegaz Asfaw, Aragaw Yimer Ahmed, Yeshimebet Ali Dawed, Ahmed Hussien Asfaw, Erkihun Tadesse Amsalu, Hamid Yimam Hassen
Soo-Peng Teoh, Yee-Yin Hoo, Raúl Murillo, María Zuluaga, Audrey Tsunoda, Dorothy Lombe, Richard Sullivan, Nirmala Bhoo-Pathy
Paromita Roy, Lateef Zameer, Debdeep Dey, Jayati Datta, Anand Bardia, Deepak Mishra
Julia Downing, Nixon Niyonzima, Eddie Mwebesa, Innocent Mutyaba, Lisa Christine Irumba, Ludoviko Zirimenya, Diana Basirika, Immacula Mbarusha, Charity Kobusingye, Margaret Happy, Alfred Jatho, Dorothy Olet Adong, Cynthia Kabagambe, Collins Mpamani, Zaitun Nalukwago, Zipporah Kyomuhangi, Joyce Zalwango, Jackson Orem, Mark Mwesiga